BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25371080)

  • 21. Histology, not lymph node involvement, predicts long-term survival in bronchopulmonary carcinoids.
    Johnson R; Trocha S; McLawhorn M; Worley M; Wheeler G; Thompson L; Schisler N; Schammel D; Schammel C; Stephenson J; Bolton W
    Am Surg; 2011 Dec; 77(12):1669-74. PubMed ID: 22273228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 35-year retrospective study of carcinoid tumors in Taiwan: differences in distribution with a high probability of associated second primary malignancies.
    Li AF; Hsu CY; Li A; Tai LC; Liang WY; Li WY; Tsay SH; Chen JY
    Cancer; 2008 Jan; 112(2):274-83. PubMed ID: 18008361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Racial and socioeconomic disparities in malignant carcinoid cancer cause specific survival: analysis of the surveillance, epidemiology and end results national cancer registry.
    Cheung R
    Asian Pac J Cancer Prev; 2013; 14(12):7117-20. PubMed ID: 24460261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.
    Kuo EJ; Salem RR
    Ann Surg Oncol; 2013 Sep; 20(9):2815-21. PubMed ID: 23771245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pulmonary carcinoid: analysis of a single institutional experience and prognostic factors].
    Correia Sda S; Pinto C; Bernardo J
    Acta Med Port; 2014; 27(6):749-54. PubMed ID: 25641291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiation therapy improves survival for unresectable postpneumonectomy lung tumors.
    Ayub A; Rehmani S; Al-Ayoubi AM; Lewis E; Santana-Rodríguez N; Clavo B; Raad W; Bhora FY
    J Surg Res; 2018 Jul; 227():60-66. PubMed ID: 29804863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The surgical spectrum of pulmonary neuroendocrine neoplasms.
    Cooper WA; Thourani VH; Gal AA; Lee RB; Mansour KA; Miller JI
    Chest; 2001 Jan; 119(1):14-8. PubMed ID: 11157578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bronchopulmonary carcinoids: surgical therapy and prognosis].
    Huwer H; Kalweit G; Krüger B; Straub U; Schäfers HJ
    Pneumologie; 1996 Nov; 50(11):786-9. PubMed ID: 9082447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modified staging system for pulmonary carcinoids on the basis of lung cancer TNM system.
    Abdel-Rahman O
    Clin Transl Oncol; 2018 May; 20(5):670-677. PubMed ID: 29022170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival of Patients with First and Metachronous Second Primary Breast Cancer or Lung Cancer Malignancy: Comparisons Using the SEER Database.
    Zhong M; He X; Lei K
    Adv Ther; 2020 May; 37(5):2236-2245. PubMed ID: 32274747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological characteristics and prognosis of resected cases of carcinoid tumors of the lung.
    Yang Z; Wang Z; Duan Y; Xu S
    Thorac Cancer; 2016 Nov; 7(6):633-638. PubMed ID: 27755793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival.
    Hubbard MO; Fu P; Margevicius S; Dowlati A; Linden PA
    J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1307-13. PubMed ID: 22361247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Retrospective study of clinicopathological characteristics in bronchopulmonary carcinoid].
    Liao H; Rao H; Zhang X; Lin Y; Jie M; Fu J; Long H; Rong T; Lin P
    Zhongguo Fei Ai Za Zhi; 2010 Jun; 13(6):591-7. PubMed ID: 20681445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A twenty-five-year follow-up of ninety-three resected typical carcinoid tumors of the lung.
    Schreurs AJ; Westermann CJ; van den Bosch JM; Vanderschueren RG; Brutel de la Rivière A; Knaepen PJ
    J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1470-5. PubMed ID: 1434731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary Carcinosarcoma: A Surveillance, Epidemiology, and End Results (SEER) Analysis.
    Ersek JL; Symanowski JT; Han Y; Howard A; Dumas K; Ahrens W; Kim E; Kim ES
    Clin Lung Cancer; 2020 Mar; 21(2):160-170. PubMed ID: 31455596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Significance of Metastatic Lymph Nodes in the Gut of Patients with Pure and Mixed Primary Appendiceal Carcinoids.
    Ciarrocchi A; Pietroletti R; Carlei F; Amicucci G
    Dis Colon Rectum; 2016 Jun; 59(6):508-12. PubMed ID: 27145307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Typical and Atypical Carcinoids of the Lung: a Surgical Treatment Strategy].
    Kaifi JT; Schmid S; Passlick B
    Zentralbl Chir; 2016 Feb; 141(1):105-20. PubMed ID: 26902582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prior cancer does not adversely affect survival in locally advanced lung cancer: A national SEER-medicare analysis.
    Laccetti AL; Pruitt SL; Xuan L; Halm EA; Gerber DE
    Lung Cancer; 2016 Aug; 98():106-113. PubMed ID: 27393515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Best prognostic factor of neuroendocrine tumors: Grade or Stage? A multidisciplinary single-center study.
    Özaslan E; Bayram F; Karaca H; Gürsoy Ş; Öztürk F; Sözüer E; Abdurrezzak Ü; Yurci A; Can Sezgin G; Yıldırım A; Başpınar O; Kula M; Özkan M
    Turk J Gastroenterol; 2016 Nov; 27(6):509-514. PubMed ID: 27852541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.